Subarachnoid Hemorrhage (SAH) 

Subarachnoid hemorrhage (SAH) is bleeding into the subarachnoid space between the arachnoid mater and pia mater where cerebrospinal fluid (CSF) circulates.

It is one of the most devastating neurological emergencies with:

  • Mortality: 25–50%
  • Significant disability among survivors
  • Peak incidence: 40–60 years

Approximately 80–85% of spontaneous SAH results from rupture of an intracranial aneurysm.


Relevant Anatomy

The subarachnoid space contains:

  • Cerebral arteries
  • Cerebral veins
  • Cranial nerves
  • CSF

Blood entering this space spreads rapidly throughout basal cisterns and ventricular system causing:

  • Raised ICP
  • Cerebral ischemia
  • Hydrocephalus
  • Vasospasm


Etiology

Aneurysmal SAH (Most Common)-80–85%

Common aneurysm locations:

Anterior circulation (85%)

  • Anterior communicating artery (ACom) (most common)
  • Posterior communicating artery (PCom)
  • Middle cerebral artery (MCA)

Posterior circulation

  • Basilar tip
  • Vertebral artery
  • PICA


Non-Aneurysmal SAH

Perimesencephalic SAH

  • Venous bleeding
  • Better prognosis
  • Rare rebleeding

Others

  • AVM rupture
  • Dural AV fistula
  • Vasculitis
  • Cerebral venous thrombosis
  • Moyamoya disease
  • Coagulopathy
  • Cocaine abuse
  • Trauma


Risk Factors

Nonmodifiable Risk Factors

Modifiable Risk Factors

Female sex

Hypertension – Most important risk factor

Age >40 years

Smoking – Strongest modifiable risk factor

Family history

Alcohol – Heavy consumption increases risk

Connective tissue disorders

Cocaine use – Markedly increases aneurysm rupture risk

• Ehlers-Danlos syndrome


• Marfan syndrome


• Autosomal Dominant Polycystic Kidney Disease (ADPKD)



Pathophysiology

Step 1: Aneurysm Rupture

Arterial blood suddenly enters subarachnoid space.


Step 2: Sudden ICP Rise

ICP may transiently approach MAP.

Consequences: Cerebral perfusion pressure

CPP=MAP−ICP

This produces:

  • Global cerebral ischemia
  • Loss of consciousness
  • Cardiac instability


Step 3: Blood Breakdown Products

Hemoglobin degradation releases:

  • Oxyhemoglobin
  • Free radicals
  • Endothelin

Leading to:

  • Endothelial injury
  • Vasoconstriction
  • Inflammation


Step 4: Delayed Cerebral Ischemia

Occurs days later.

Major cause of morbidity.


Step 5: Hydrocephalus

Blood blocks:

  • Arachnoid granulations
  • CSF pathways

Result:Acute obstructive hydrocephalus.


Clinical Presentation

Classic Symptom

Thunderclap Headache

Patient often says:”Worst headache of my life”

Characteristics:

  • Abrupt
  • Seconds to minutes
  • Explosive onset

Occurs in >90%.


Associated Symptoms

Meningeal Irritation

  • Neck stiffness
  • Photophobia
  • Vomiting


Neurological Symptoms

  • Altered sensorium
  • Seizures
  • Focal deficits
  • Coma


Cranial Nerve Palsies

CN III palsy-Suggests PCom aneurysm.

Features:

  • Ptosis
  • Dilated pupil
  • Ophthalmoplegia


Sentinel Headache

  • Occurs days to weeks before rupture.
  • Represents minor aneurysm leak.
  • Seen in 10–40%.


Physical Examination

Vital Signs

May show:

  • Severe hypertension
  • Bradycardia
  • Cushing response


Neurological Findings

  • Meningismus
  • Reduced GCS
  • Focal deficits
  • Coma


Diagnosis

Non-Contrast CT Head-First-line investigation.

Time

Sensitivity

<6 h

>95–99%

6–24 h

90–95%

>3 days

Falls significantly

Typical findings:

  • Basal cistern blood
  • Sylvian fissure blood
  • Intraventricular hemorrhage
  • Hydrocephalus


Lumbar Puncture

Indication:High suspicion despite negative CT.

Look for:Xanthochromia

Best detected:12 hours–2 weeks

Findings:

  • Bilirubin in CSF
  • Persistent RBCs


CT Angiography (CTA)

Current standard vascular imaging.

Identifies:

  • Aneurysm
  • AVM
  • Vasospasm

Sensitivity >95%.


Digital Subtraction Angiography (DSA)

Gold standard.

Used when:

  • CTA negative
  • High suspicion remains
  • Endovascular planning

MRI

Useful later.

Sequences:

  • FLAIR
  • GRE
  • SWI

Less useful in hyperacute setting.


Severity Grading

Hunt and Hess Scale

Grade

Findings

I

Mild headache

II

Severe headache, nuchal rigidity

III

Drowsiness/confusion

IV

Stupor

V

Coma


WFNS Grade-Based on GCS.

Grade

GCS

I

15

II

13–14

III

13–14 + deficit

IV

7–12

V

3–6


Fisher Scale-CT-based.

Grade

Blood

1

No blood

2

Thin SAH

3

Thick SAH

4

IVH or ICH


Modified Fisher Scale

Most used today.

Grade

SAH

IVH

0

No SAH

No

1

Thin

No

2

Thin

Yes

3

Thick

No

4

Thick

Yes

Higher grade = higher vasospasm risk.


Emergency Stabilization

ABC Approach

Blood Pressure Management

  • Before Aneurysm Securing Major goal:Prevent rebleeding.
  • Current recommendations:SBP Target Usually:120–160 mmHg


Preferred Antihypertensives

Drug

Comment

Nicardipine infusion

Most commonly used

Clevidipine infusion

Excellent titratable agent

Labetalol bolus/infusion

Commonly used

Esmolol

Occasionally used

Avoid:

Drug

Reason

Nitroprusside

May increase ICP

Nitroglycerin

May increase ICP

Hydralazine

Unpredictable effect

Definitive Aneurysm Treatment

Should occur as early as possible (usually within 24 h).


Endovascular Coiling

Current preferred approach in many aneurysms.

Advantages:

  • Less invasive
  • Better short-term outcomes


Surgical Clipping

Preferred when:

  • MCA aneurysm
  • Large hematoma
  • Complex anatomy


Rebleeding

Highest Risk Period-First 24 hours.

Prevention

  • Early coiling/clipping
  • BP control
  • Avoid agitation

Tranexamic Acid

ULTRA trial showed that ultra-early (<24 h), short-course TXA reduces rebleeding tendency but does not improve 6-month functional outcome in aneurysmal SAH; therefore routine TXA use is not recommended.


Delayed Cerebral Ischemia (DCI)

Most important delayed complication.

Occurs:Day 4–14

Peak:Day 7–10


Mechanism

Not solely vasospasm.

Also:

  • Microthrombosis
  • Inflammation
  • Cortical spreading depolarization


Clinical Features

New:

  • Weakness
  • Aphasia
  • Reduced consciousness


Diagnosis

  • TCD-Mean MCA velocity:
  • 120 cm/s suggests vasospasm
  • 200 cm/s severe vasospasm
  • Lindegaard ratio >3–6.
  • CTA-Useful screening tool.
  • DSA-Gold standard.


Prevention of Vasospasm—Nimodipine

  • Only therapy proven to improve neurological outcome.
  • Dose-60 mg orally/NG every 4 h
  • Duration:-21 days
  • If hypotension:-30 mg every 2 h.
  • Give to all aneurysmal SAH patients unless contraindicated.

Treatment of Symptomatic Vasospasm/DCI

Step 1

Optimize:Oxygenation/Hemoglobin/Volume status


Step 2

Induced Hypertension Recommended for sympt-omatic DCI after aneurysm securing.

Goal:

Increase cerebral blood flow through narrowed vessels.


Common Targets

Severity

SBP Target

Mild DCI

160–180 mmHg

Moderate DCI

180–200 mmHg

Severe DCI

Up to 220 mmHg in selected patients

or

Parameter

Target

MAP

90–130 mmHg

Targets are individualized.


Vasopressors Used

Drug

Preferred?

Norepinephrine

Yes

Phenylephrine

Yes

Vasopressin

Occasionally

Dopamine

Rarely

Step 3

Endovascular Therapy

Balloon angioplasty

Best for proximal vessels.

Intra-arterial vasodilators

Examples:

  • Verapamil
  • Nicardipine
  • Milrinone


Triple-H Therapy

Historical:

  • Hypertension
  • Hypervolemia
  • Hemodilution

No longer recommended.

Current practice:Euvolemia + induced hypertension only.


Hydrocephalus

Occurs in 15–30%.

Features:

  • Reduced consciousness
  • Enlarged ventricles
  • ICP elevation

Treatment—External Ventricular Drain (EVD)

Gold standard.

Provides:

  • CSF diversion
  • ICP monitoring

Current Practice

  • Periprocedural antibiotic prophylaxis commonly used
  • Prolonged antibiotics for entire EVD duration are not recommended

Typical example:

  • Cefazolin before insertion

Extended prophylaxis has not shown benefit and increases resistant organisms.


ICP Management

Treat when:ICP >20–22 mmHg

Measures:

  • Head elevation 30°
  • Sedation
  • Analgesia
  • CSF drainage
  • Hyperosmolar therapy


Hypertonic Saline

Preferred in many ICUs.


Mannitol

0.25–1 g/kg

Useful when:

  • ICP crisis
  • Hemodynamic stability


Seizures

Incidence:6–20%

Risk factors:

  • Cortical hematoma
  • MCA aneurysm
  • Rebleeding


Antiepileptic Therapy

Not routinely given long-term.

Short-course prophylaxis may be used in:

  • High-risk patients
  • Early seizures

Common agents:

  • Levetiracetam
  • Valproate


Sodium Disorders

Very common.


  • SIADH
  • Cerebral Salt Wasting


Cardiac Complications

Due to catecholamine surge.

-ECG Changes

  • QT prolongation
  • ST changes
  • T-wave inversion

-Arrhythmias—AF/VT/Bradycardia

-Stress Cardiomyopathy

Neurogenic stunned myocardium.

Can mimic MI.

Echo:

  • Reduced EF
  • Regional dysfunction


Pulmonary Complications

  • Neurogenic pulmonary edema
  • ARDS
  • Aspiration pneumonia


ICU Monitoring

Daily assessment:

  • Neurological examination
  • GCS
  • Pupils
  • TCD
  • Electrolytes
  • Fluid balance


ICU Targets

Parameter

Target

SpO₂

>94%

PaO₂

>80 mmHg

Temperature

Normothermia

Glucose

140–180 mg/dL

Sodium

Normal range

CPP

>60–70 mmHg

ICP

<20–22 mmHg


Pharmacologic DVT Prophylaxis

Key Principle Balance: Rebleeding risk vs thrombosis risk


-Before Aneurysm Securing

Usually Avoid

UFH/LMWH generally withheld until aneurysm is secured.

Reason:Potential risk of catastrophic rebleeding.


=After Coiling or Clipping

Once:

  • Aneurysm secured
  • Repeat imaging stable
  • Neurosurgical approval obtained

Then start:

Options

Drug

Dose

Enoxaparin

40 mg SC daily

UFH

5000 U SC q8–12h

Usually within 24–48 hours after securing aneurysm if no bleeding concern.


EVD Present?

Modern practice:Pharmacologic prophylaxis can still be used

After:

  • Stable CT
  • Neurosurgical agreement

Temporary withholding around EVD insertion/removal is common.


Clinical Perals

  1. ACom aneurysm = most common aneurysm causing SAH.
  2. Thunderclap headache = hallmark presentation.
  3. Non-contrast CT is first investigation.
  4. Negative CT + high suspicion LP for xanthochromia.
  5. DSA = gold standard vascular study.
  6. Rebleeding risk highest during first 24 hours.
  7. Nimodipine is the only drug proven to improve neurological outcome.
  8. Vasospasm typically occurs day 3–14, peaks day 7.
  9. DCI is now considered more important than angiographic vasospasm alone.
  10. Triple-H therapy is obsolete.
  11. EVD is treatment of acute hydrocephalus.
  12. Induced hypertension is used for symptomatic DCI after aneurysm securing.
  13. Hyponatremia after SAH is commonly due to SIADH or cerebral salt wasting.
  14. Neurogenic stunned myocardium is a classic extracranial complication.
  15. Early aneurysm coiling/clipping is the single most important intervention to prevent rebleeding.